AI Enhances Evaluation of Crohn’s Disease Through Colonoscopy
AI improves Crohn’s disease evaluation via colonoscopy, matching gastroenterologists’ performance in identifying mucosal ulceration. π€π
September 12, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
MIT Develops New Antibiotics Using AI to Combat Drug-Resistant Infections
MIT researchers have developed new antibiotics using AI to target drug-resistant bacteria like MRSA and gonorrhea. π¦ π
September 5, 2025
Transformative Role of Artificial Intelligence in Drug Discovery and Translational Medicine: Innovations, Challenges, and Future Prospects.
AI revolutionizes drug discovery, reducing costs by 30% and development time by 50%. Ethical challenges persist. π€π
September 5, 2025
AI Enhances RNA Vaccine and Therapy Development
AI aids in designing nanoparticles for RNA vaccine delivery, enhancing efficiency and potential treatments for various diseases. π§¬π
September 5, 2025
Lung lobe segmentation: performance of open-source MOOSE, TotalSegmentator, and LungMask models compared to a local in-house model.
Lung lobe segmentation tools evaluated: TotalSegmentator excels, while data diversity enhances model accuracy. ππ«
September 5, 2025
The future of pharmaceuticals: Artificial intelligence in drug discovery and development.
AI transforms drug discovery, enhancing efficiency and reducing costs. Key advancements in clinical trials and molecular generation. ππ€
September 3, 2025
Systematic benchmarking of 13 AI methods for predicting cyclic peptide membrane permeability.
Benchmarking 13 AI methods for cyclic peptide permeability reveals DMPNN’s superior performance. Key insights on molecular representation and model architecture. ππ¬
August 29, 2025
Harnessing AI-driven reverse docking in drug discovery: a comprehensive review of opportunities, challenges, and emerging trends.
AI-driven reverse docking revolutionizes drug discovery, enhancing target identification and repurposing. Key insights from PubMed review. ππ€
August 26, 2025
AI Model Enhances mRNA Therapeutics Development for Diseases
AI model RiboNN enhances mRNA therapeutics development, predicting protein production efficiency for diseases like cancer and genetic disorders. π§¬π
August 8, 2025
Development of LRRK2 inhibitors through computational strategies: a promising avenue for Parkinson’s disease.
Exploring LRRK2 inhibitors for Parkinson’s: AI-driven strategies show promise in drug discovery. π§ π
August 7, 2025